PCI Hosts its 7th Annual Innovation@Penn Conference
On January 9th, 2023 PCI was proud to present a star-studded program entitled “The Future of mRNA Technology” at Wharton San Francisco during the JP Morgan Healthcare Conference.
Penn Startups Raising Money in 2023
There are a wide range of Penn spinouts across industries that are working on innovative and transformative products and projects. This is a list of Penn startups currently raising money in 2023.
PCI Ventures @ Pennovation Works Showcase Shines Spotlight on Penn-Affiliated Startups Making a Difference
PCI Ventures, a division of PCI specifically focused on creating early-stage businesses founded on Penn technology, recently held a showcase at Pennovation Works.
Penn Spinout and I-Corps Participant Innervace Raises $40 Million for Parkinson’s Disease Research
The funds will allow Innervace to advance their platform and lead asset in Parkinson’s disease, which aims to reconstruct the neuronal circuitry that is lost in Parkinson's patients.
Sesen Bio and Carisma Therapeutics Announce Merger Agreement
The combined company, which is expected to operate under the name Carisma Therapeutics Inc., will focus on advancing Carisma’s proprietary cell therapy platform.
Penn Medicine to Conduct New Clinical Trial to Evaluate Safety and Efficacy of Chewing Gum Designed by School of Dental Medicine Researchers to Trap SARS-CoV-2 in Saliva
The trial will recruit participants from a pool of Penn Medicine employees whose responses to the PennOpen Pass screening system indicate that they may be infected with COVID-19.
PCI Startup Vital Start Health Wins 2022 Citizens Small Business Community Champions Award for their Work in Neonatal Care
PCI startup Vital Start Health empowers clinicians and caregivers by giving them a digital platform to improve neonatal care.
President’s Innovation Prize Winner Lumify Care and PCI Startup Neuralert Hit Major Milestones in 2022
Lumify Care and Neuralert have grown rapidly in terms of funding and product expansion.
Penn spinout Verismo Therapeutics Makes Agreement to Fund University Research of KIR-CAR platform of Car-T to Target Solid Tumors
Learn about Penn spinout Verismo Therapeutics' agreement to fund four years of university research of KIR-CAR platform of Car-T to target solid tumors.
The Future of Research-Based Innovation Hubs with the Rise of Remote Work
John Swartley and Bhavana Mohanraj discuss how working remotely will impact research and innovation hubs.